EU ARCHIVE
- Coop Pank 2025 audited Annual Report
No differences found in audited accounts compared to unaudited financial results.
- Kaixin Holdings Announces Share Consolidation
Kaixin Holdings to effect 1-for-15 share consolidation, with new par value of $20.25 per share, effective March 13, 2026.
- Cineplex Reports February Box Office Results
$32.4 million
- Ocean Power Technologies, Inc. Pre Releases Third Quarter Fiscal 2026 Results
Record backlog drives growth momentum for fiscal Q3 2026
- Stardust Power Announces Year End 2025 Earnings Release Date, Conference Call
Stardust Power to report Q4 2025 earnings on February 25, 2026; conference call scheduled for the same day; details to be shared on investor relations website.
- Vima Therapeutics Announces First Dystonia Patient Dosed in Phase 2 Study and Extension of Series A to $100 Million to Advance Potential First-in-Class Oral Therapy for Dystonia and Parkinson’s Disease
Vima Therapeutics announces Phase 2 trial start for VIM0423 in isolated dystonia, with $100M in Series A funding to advance oral therapy for dystonia and Parkinson's disease.
- Calian VENTURES and Tessellate Robotics Advance Autonomous Navigation for Arctic Defence
Calian VENTURES and Tessellate Robotics collaborate on autonomous navigation tech for Arctic defence
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
CRISPR Therapeutics AG issues $550 million convertible senior notes due 2031, upsized from $350 million, expected to close on March 16, 2026.
- Beyond Air to Participate in the 38th Annual Roth Conference in March
Beyond Air CEO to speak at Roth Conference
- Next Hydrogen Secures Contracts Totaling $3.75 Million for Specialized Nuclear Application
Next Hydrogen Solutions Inc. wins $3.75 million contracts for nuclear application demonstration of its electrolyzer technology.
- Xanadu and ETRI Partner to Accelerate Fault-Tolerant Quantum Algorithm Design using PennyLane
Xanadu and ETRI Partner to Accelerate Fault-Tolerant Quantum Algorithm Design
- GT Biopharma to Participate in the 38th Annual Roth Conference
GT Biopharma to participate in 38th Annual Roth Conference.
- H&R Block Canada's Free Tax Filing Program Marks 10 Years of Hands-On Individualized Tax Expert Support for Vulnerable Canadians
H&R Block Canada's free tax filing program offers 10 years of hands-on individualized tax expert support for vulnerable Canadians.
- Balearic builders warn that rising oil prices due to the war in Iran pose threat to construction projects
Construction projects in the Balearics face financial strain due to rising oil prices.
- Europe E-Bike Market to Hit USD 10,821.6 Million by 2034 with a Robust CAGR of 6.00%
The Europe E-Bike Market size reached USD 6,431.5 Million in 2025.
- Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Kala Bio launches AI agent for biotech; first purpose-built AI agent for biotech expected to ship within 14 days; $180 billion agentic AI healthcare revolution accelerates
- GBP: Yield support and resilience versus energy shock – MUFG
Pound supported by UK yield jump, BoE rate-cut pricing reduction
- Multitude Capital Oyj successfully places EUR 70 million in perpetual bonds qualifying as IFRS equity
Multitude Capital Oyj has successfully placed EUR 70 million in subordinated perpetual capital notes qualifying as IFRS equity.